首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Quantification of breast cancer cells in peripheral blood samples by real-time RT-PCR
【24h】

Quantification of breast cancer cells in peripheral blood samples by real-time RT-PCR

机译:通过实时RT-PCR定量检测外周血样本中的乳腺癌细胞

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Circulating tumour cells (CTCs) are cells that have detached from a primary tumour, circulate in the peripheral blood, and are considered to be the main root of distant metastases. We present a method for the detection of CTCs by real-time PCR on different cytokeratin markers. Materials and Methods: Blood samples of a healthy donor were mixed with specific numbers of cells from different breast carcinoma cell line cells. RNA was isolated from the samples and transcribed into cDNA. TaqMan real-time PCR for cytokeratins 8, 18 and 19 was carried out and was correlated to that of 18S. Results: Cytokeratin gene expression increased in all samples, when as few as 10 tumour cells were added. In the CAMA-1 cell line, the increase was even greater the more cells were added. Conclusion: By this methodology, cells from mammary carcinoma cell lines can be detected in blood samples. Its benefit will be validated in samples from patients with breast cancer.
机译:背景:循环肿瘤细胞(CTC)是与原发肿瘤分离,在外周血中循环的细胞,被认为是远处转移的主要根源。我们提出了一种通过实时PCR检测不同细胞角蛋白标记物检测CTC的方法。材料和方法:将健康供体的血液样本与特定数量的来自不同乳腺癌细胞系细胞的细胞混合。从样品中分离出RNA,并转录成cDNA。 TaqMan实时PCR用于细胞角蛋白8、18和19,并与18S相关。结果:当添加少至10个肿瘤细胞时,所有样品中的细胞角蛋白基因表达均增加。在CAMA-1细胞系中,添加的细胞越多,增加的幅度就越大。结论:通过这种方法,可以在血液样本中检测到来自乳腺癌细胞系的细胞。它的益处将在乳腺癌患者的样本中得到验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号